Cargando…

Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants

BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementa...

Descripción completa

Detalles Bibliográficos
Autores principales: Korpela, Katri, Salonen, Anne, Vepsäläinen, Outi, Suomalainen, Marjo, Kolmeder, Carolin, Varjosalo, Markku, Miettinen, Sini, Kukkonen, Kaarina, Savilahti, Erkki, Kuitunen, Mikael, de Vos, Willem M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192119/
https://www.ncbi.nlm.nih.gov/pubmed/30326954
http://dx.doi.org/10.1186/s40168-018-0567-4
_version_ 1783363844792385536
author Korpela, Katri
Salonen, Anne
Vepsäläinen, Outi
Suomalainen, Marjo
Kolmeder, Carolin
Varjosalo, Markku
Miettinen, Sini
Kukkonen, Kaarina
Savilahti, Erkki
Kuitunen, Mikael
de Vos, Willem M
author_facet Korpela, Katri
Salonen, Anne
Vepsäläinen, Outi
Suomalainen, Marjo
Kolmeder, Carolin
Varjosalo, Markku
Miettinen, Sini
Kukkonen, Kaarina
Savilahti, Erkki
Kuitunen, Mikael
de Vos, Willem M
author_sort Korpela, Katri
collection PubMed
description BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementation could ameliorate the effects of antibiotic use or caesarean birth on infant microbiota in a double blind, placebo-controlled randomized clinical trial. Mothers were given a multispecies probiotic, consisting of Bifidobacterium breve Bb99 (Bp99 2 × 10(8) cfu) Propionibacterium freundenreichii subsp. shermanii JS (2 × 10(9)cfu), Lactobacillus rhamnosus Lc705 (5 × 10(9) cfu) and Lactobacillus rhamnosus GG (5 × 10(9) cfu) (N = 168 breastfed and 31 formula-fed), or placebo supplement (N = 201 breastfed and 22 formula-fed) during pregnancy, and the infants were given the same supplement. Faecal samples of the infants were collected at 3 months and analyzed using taxonomic, metagenomic and metaproteomic approaches. RESULTS: The probiotic supplement had a strong overall impact on the microbiota composition, but the effect depended on the infant’s diet. Only breastfed infants showed the expected increase in bifidobacteria and reduction in Proteobacteria and Clostridia. In the placebo group, both birth mode and antibiotic use were significantly associated with altered microbiota composition and function, particularly reduced Bifidobacterium abundance. In the probiotic group, the effects of antibiotics and birth mode were either completely eliminated or reduced. CONCLUSIONS: The results indicate that it is possible to correct undesired changes in microbiota composition and function caused by antibiotic treatments or caesarean birth by supplementing infants with a probiotic mixture together with at least partial breastfeeding. TRIAL REGISTRATION: clinicaltrials.gov NCT00298337. Registered March 2, 2006. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40168-018-0567-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6192119
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61921192018-10-23 Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants Korpela, Katri Salonen, Anne Vepsäläinen, Outi Suomalainen, Marjo Kolmeder, Carolin Varjosalo, Markku Miettinen, Sini Kukkonen, Kaarina Savilahti, Erkki Kuitunen, Mikael de Vos, Willem M Microbiome Research BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementation could ameliorate the effects of antibiotic use or caesarean birth on infant microbiota in a double blind, placebo-controlled randomized clinical trial. Mothers were given a multispecies probiotic, consisting of Bifidobacterium breve Bb99 (Bp99 2 × 10(8) cfu) Propionibacterium freundenreichii subsp. shermanii JS (2 × 10(9)cfu), Lactobacillus rhamnosus Lc705 (5 × 10(9) cfu) and Lactobacillus rhamnosus GG (5 × 10(9) cfu) (N = 168 breastfed and 31 formula-fed), or placebo supplement (N = 201 breastfed and 22 formula-fed) during pregnancy, and the infants were given the same supplement. Faecal samples of the infants were collected at 3 months and analyzed using taxonomic, metagenomic and metaproteomic approaches. RESULTS: The probiotic supplement had a strong overall impact on the microbiota composition, but the effect depended on the infant’s diet. Only breastfed infants showed the expected increase in bifidobacteria and reduction in Proteobacteria and Clostridia. In the placebo group, both birth mode and antibiotic use were significantly associated with altered microbiota composition and function, particularly reduced Bifidobacterium abundance. In the probiotic group, the effects of antibiotics and birth mode were either completely eliminated or reduced. CONCLUSIONS: The results indicate that it is possible to correct undesired changes in microbiota composition and function caused by antibiotic treatments or caesarean birth by supplementing infants with a probiotic mixture together with at least partial breastfeeding. TRIAL REGISTRATION: clinicaltrials.gov NCT00298337. Registered March 2, 2006. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40168-018-0567-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-16 /pmc/articles/PMC6192119/ /pubmed/30326954 http://dx.doi.org/10.1186/s40168-018-0567-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Korpela, Katri
Salonen, Anne
Vepsäläinen, Outi
Suomalainen, Marjo
Kolmeder, Carolin
Varjosalo, Markku
Miettinen, Sini
Kukkonen, Kaarina
Savilahti, Erkki
Kuitunen, Mikael
de Vos, Willem M
Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title_full Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title_fullStr Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title_full_unstemmed Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title_short Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
title_sort probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192119/
https://www.ncbi.nlm.nih.gov/pubmed/30326954
http://dx.doi.org/10.1186/s40168-018-0567-4
work_keys_str_mv AT korpelakatri probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT salonenanne probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT vepsalainenouti probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT suomalainenmarjo probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT kolmedercarolin probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT varjosalomarkku probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT miettinensini probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT kukkonenkaarina probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT savilahtierkki probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT kuitunenmikael probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants
AT devoswillemm probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants